Exhibitors Register On-line

As we hold the 2013 CSAM State of the Art Conference, a transformational change in substance abuse treatment will begin to unfold.

27 million uninsured Americans will begin signing up for the health insurance exchanges mandated under the Affordable Care Act (ACA). While currently only nine percent of the 21.6 million who need it receive specialty substance abuse treatment (NSDUH 2011), by requiring that substance abuse treatment and prevention be considered "essential services," many of those ninety-one percent will now gain access. To treat this huge influx of patients, addiction medicine and primary care providers need to partner effectively.

Thursday Morning: Improving the Dialogue Between Addiction Medicine and Primary Care

Thursday Afternoon: Research For the Clinician

Friday Morning: Managing Prescription Drug Abuse and Pain

Friday Afternoon: Engagement and Relapse Prevention

Saturday Morning: Best Clinical Practices

Additional Highlights: We are privileged to have George Vaillant, MD, as our discussant for a showing of clips from the 2012 documentary, Bill W. on Thursday evening. This year's State of the Art Conference will offer more opportunities for interacting with other participants: facilitated discussions at your tables; lunch at interest tables with colleagues; a poster session highlighting education projects and practice; a 12-step demonstration meeting; and, Friday evening, a marina BBQ dinner accompanied by the Steve Feierabend Jazz Trio.

Sharone Abramowitz, MD, Conference Chair
Director, Behavioral and Addiction Medicine, Primary Care Medicine, Alameda Health System; Psychiatrist, Oakland and
San Francisco.

Conference Planners

  • Sharone A. Abramowitz, MD, Chair
  • Jean A. Marsters, MD, Vice-Chair
  • Monika A. Koch, MD, Education Committee Chair
  • Anthony P. Albanese, MD
  • Asma Asyyed, MD
  • William S. Brostoff, MD
  • Timmen L. Cermak, MD
  • Steven J. Eickelberg, MD
  • Murtuza Ghadiali, MD
  • Dana Harris, MD
  • David Y Kan, MD
  • Paula J. Lum, MD, MPH
  • Karen A. Miotto, MD
  • Kenneth A. Saffier, MD
  • Mario F. San Bartolome, MD, MBA
  • Maureen Strohm, MD

Conference Information


The conference hotel is the Sheraton San Diego Hotel and Marina. The hotel is located near San Diego International Airport and has a free hotel shuttle that runs every 20 minutes. There are a limited number of rooms available at the conference rate of $169 for a single or double room through September 23. If you wait until near the September 23 deadline there is no guarantee that rooms will still be available.

Call 877-734-2726 for a reservation and make sure that you mention the CSAM Addiction Medicine State of the Art Conference to get the special rate. Book your room.

Who Should Attend

  • Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice;
  • Primary care clinicians who want to get a better understanding of addiction and how to effectively manage patients with addictions in their practice;
  • Public health officials who want an understanding of the implications of the current state of addiction policy and treatment;
  • Non-physicians who are involved in the treatment of addicted patients.

Call For Poster Abstracts

All attendees who are involved in medical education or practice-based clinical research are invited to submit abstracts for posters to be displayed at the State of the Art conference. Abstracts are due July 8. The Medical Education and Research Foundation for the Treatment of Addiction with CSAM’s Committee on Education will review proposals and notify applicants by August 6. Abstracts should be no longer than 400 words and be non-proprietary. For more information on submissions go to www.MERFweb.org or contact merfadmin@gmail.com.

Twelve-Step/Mutual Help Meetings

Meetings daily at 7:00 am and 9:00 pm starting on Wednesday evening.

Educational Information & Fees

Educational Objectives

At the conclusion of this conference participants should be able to:

Develop a strategy for working in a primary-care team setting;
Utilize safe prescribing, monitoring, and prevention counseling techniques when prescribing opioids for chronic pain;
Discuss the latest evidence on the cognitive impact of early marijuana use with patients and their families;
Implement evaluation and treatment techniques to better serve geriatric patients with substance use disorders;
Utilize relapse and prevention counseling techniques in your practice when managing alcohol and substance use disorders;
Apply therapies other than benzodiazepines for alcohol detoxification when appropriate.

A complete set of educational objectives for the conference will be posted on the conference website.


The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians.

CSAM takes responsibility for the content, quality and scientific integrity of this CME activity. CSAM designates this live educational activity for a maximum of 29 AMA PRA Category 1 Credits™ (see below). Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.

Pre-Conference Workshops (Wed.) 7 Credits
State of the Art Conference (Thurs.-Sat.) 18.5 Credits
Opioid Prescribing and Safe Use (Sat.) 3 Credits
(through American Society of Addiction Medicine)

CEU/CE Credit is available for psychologists, therapists, drug abuse counselors, nurses and physician assistants. See CSAM website for details.


  ASAM/CSAM Member Non-Member Physician Other Health Professional Medical
State of the Art Conference Thurs – Sat $745 $945 $745 $200 $50
Pre-Conference Workshop Wed (per workshop) $140 $180 $140 $40 $20
Thursday or Friday (one-day registration) $300 $400 $300 $80 $20
Saturday (one day registration) $150 $200 $150 $40 $10

Three-day registration includes continental breakfast and breaks daily, reception and movie on Thursday, BBQ dinner on the Marina on Friday. All registrants will receive a USB drive with the syllabus and access to a download site. $50 additional for printed syllabus.

Special Events

Thursday, October 17, 7:30 pm

Movie Night with Popcorn and Discussion
(Guests welcome)
Excerpts from the documentary "Bill W." about the co-founder of Alcoholics Anonymous and discussion with George Vaillant, MD, Professor at Harvard Medical School, Former AA Trustee and author of Natural History of Alcoholism, Revisited
"Laudatory but never simplistic, "Bill W." is a thoroughly engrossing portrait of Wilson, his times and the visionary fellowship that is his legacy."
— Los Angeles Times

Friday, October 18, 6:00 pm

BBQ Dinner on the Marina
Included in conference registration, guests welcome with additional fee
While listening to live jazz, relax and mingle with fellow attendees, Southern California-style, overlooking the San Diego Marina.

Saturday, October 19, 12:30 pm to 4:00 pm

ER/LA Opioid REMS Course:
Achieving Safe Use While Improving Patient Care

Jointly sponsored with the American Society of Addiction Medicine and the California Academy of Family Physicians and the Collaborative for REMS Education (CO*RE)
(Free for all physicians. Registration is limited and pre-registration required. Box lunch included.)

FDA statistics indicate that more than 33 million Americans, teens and older, misused extended-release and long-acting (ER/LA) opioids during 2007, up from 29 million in 2002. Yet these drugs have long been a major tool in the management of chronic pain or to help those who suffer from a painful injury or surgery. Highly effective yet highly addictive, the challenge posed by ER/LA opioids-patient assessment, prescribing guidelines, managing treatment and addressing alternatives when opioids fail—are the critical issues addressed by ER/LA Opioid REMS: Achieving Safe Use While Improving Patient Care course.

In response to the growing problem of the abuse, misuse and diversion of Extended Release/Long Acting (ER/LA) Opioid drugs, the FDA approved a risk evaluation and mitigation strategy (REMS) for ER/LA opioid medications. This initiative will provide a unique opportunity to reach and provide effective prescriber-focused education on the safe and effective prescribing of ER/LA opioids to safely manage pain.